← Open Payments lookup

JESSICA COOLEY: Open Payments

NPI 1720482441 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,181 in 77 payments from 16 companies in 2025. Trend: 2023 $1,212 · 2024 $1,293 · 2025 $1,181

Food & beverage: $1,181
CompanyPaymentsAmount
Astellas Pharma US Inc8$205
PFIZER INC.11$166
Amgen Inc.24$137
Novartis Pharmaceuticals Corporation4$102
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$75
ABBVIE INC.3$69
Otsuka America Pharmaceutical, Inc.3$69
GlaxoSmithKline, LLC.3$63
Merck Sharp & Dohme LLC3$62
AstraZeneca Pharmaceuticals LP3$47

Products named: Veozah, OTEZLA, ELIQUIS, LEQVIO, XIFAXAN, REXULTI, TRELEGY ELLIPTA, ROTATEQ.

Industry payments across AZ — which companies pay providers there.